Outsourcing in Clinical Trials East Coast 2021
Virtual Event
25th-26th May, 2021
Download Agenda
Outsourcing in Clinical Trials East Coast 2021
Advertisement
Outsourcing in Clinical Trials East Coast 2021 has a new date! We are pleased to announce that we will be going ahead on our brand new online event platform on our new dates of 25-26 May 2021!
Discover effective strategies for outsourcing clinical trial operations to ensure studies run smoothly and within budget.
The 2021 programme will feature a range of speakers from the likes of GlaxoSmithKline, Novartis, Pfizer, BMS any many more, who through a variety of interactive session formats will offer insight on promoting successful collaboration between the clinical trials community. Attendees will have the opportunity of taking part in sessions across 3 stages, each focusing on a different topic area. Whether your role is Clinical Operations, Technology & Innovation or Clinical Data Management this event can not be missed
We look forward to seeing you there!
A FANTASTIC NETWORK OF YOUR PEERS AND COLLEAGUES RIGHT AT A TAP OR CLICK OF A BUTTON
Simply register, login on the day and get ready to connect and learn. With the right network at your fingertips, learning and connecting have never been so easy.
💻 Watch live and recorded thought leadership presentations
🗣️ Take part in live Q&A with industry experts from across the globe
👩💻 One-to-one & group video chat with each solution provider
🤝 Chat & network with anyone on the platform
📊 Take part in our interactive polls
👥 Join live panel debates and discussions
🛍️ Download resources from solution providers to your event bag
Why Attend?
NETWORK
-
OCT East Coast providers an exceptional networking opportunity for the local Philadelphia biopharma industry, giving attendees the chance to re-discover connections and make new contacts across the region
LEARN
-
OCT East Coast has a focus on interactivity; moving away from stale presentation, this event offers all attendees the chance to join the conversation and have their voice heard
Discover
-
The exhibition will showcase 50 of the best in business vendors for clinical trials, whatever your need OCT East Coast will have the answer

Susan Lubin
Director Clinical Pharmacology and Oncology Operations,Bristol Myers Squibb
Biography:
- Susan has 20+ years of experience working in the early development space with Bristol-Myers Squibb
- She is a RN with a Masters Degree in Health Care Administration
- Has held a variety of roles such as Administrator of BMS Phase 1 Clinic, Outsourcing Manager and recently is the Director of Clinical Pharmacology and Oncology Operations
Session Details: Is the Full Service Approach the Best Outsourcing Model When Working with Tight Timelines and Budgets? Exploring the Options to Help us Come to the Best Decision 25-05-2021, 11:45 am View In Agenda

Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health,
Biography: Dr. Ram Raju has a distinguished career over 40 years as a healthcare provider, teacher, researcher and community organizer. In his role at Northwell Health, Dr. Raju set the strategic vision to improve population health by finding ways to meet the needs of its most vulnerable communities, by examining the existing programs aimed at improving the health system's response to the community's needs and working with local organizations to address them. Northwell Health is the largest healthcare provider in the state of New York, is a system with 23 hospitals and 830 outpatient facilities that sees 2 million people every year in the New York metro area and beyond.
Session Details: PANEL DISCUSSION Studying the Importance of Getting A Diverse Patient Group Onto Your Study 25-05-2021, 11:45 am View In Agenda

Jigna Parekh
Senior Clinical Trial Manager,Incyte
Biography: Jigna Parekh is a registered Pharmacist with a degree in PharmD and MS in Pharmacology & Toxicology. Dr. Parekh has over 12 years of experience working in clinical research with extensive knowledge of phase I, II, III, extension clinical trials (in-patient and out-patient studies). She has managed diversified global clinical trials that are in-house based, consortium, fully outsourced and partially outsourced in various therapeutic areas such as Rare disease indications, Oncology (adult and pediatric), CVS, CNS, Respiratory (adult and adolescent) and Diabetes. She has experience working for both CRO & Sponsor in clinical trial conduct and presents strong leadership, decision-making and problem-solving skills. Dr. Parekh joined Incyte not very long ago as a Senior Clinical Trial Manager and is very excited to join the team. She is currently managing rare disease clinical trials at the Incyte’s Inflammation & AutoImmunity (IAI) group. In addition, Dr. Parekh interacts with media with regards to clinical trial processes, presenter at the Clinical trial conferences. She also has paper publications and a peer-reviewer of scientific journals.
Session Details: View In Agenda

Behtash Bahador MS
Director, Health Literacy,CISCRP
Biography: Behtash Bahador is an Associate Director at the non-profit organization CISCRP, and holds a Master of Science in Health Communication from the Tufts University School of Medicine. Since 2014, he has collaborated with a range of stakeholder groups to establish and implement patient- and public-centric initiatives across the life-cycle of drug and treatment development. This has included supporting the development of regulatory and cross-disciplinary best practice guidelines, operationalizing key elements of evidence-based public health programing into research engagement activities, and always keeping the needs of patients, participants and the public at the forefront of his work.
Session Details: This is Not a Trend: Exploring Why Patient-Centered Clinical Research Will Continue to Change the Research Paradigms of the Past and the Impact it Can Have 25-05-2021, 12:45 pm View In Agenda

Sameer Tandon
Digital Strategy Lead, Clinical Trial Innovation,Novartis
Biography: Sameer is a senior executive with over 24 years of both pharma/CRO experience in operations, feasibility, site selection, business development, procurement, strategic planning, and project management. Recent roles have focused on innovative approaches to support digital solutions integrated in our clinical trials to reduce patient burden and maximize efficiency in site selection and patient recruitment.
Session Details: View In Agenda

Ratan Ratnesh
Director of Clinical Outsourcing,Otsuka
Biography: Ratan Ratnesh is a Director and Head of Clinical Outsourcing at Otsuka Pharmaceutical. He received his Bachelors in Mechanical Engineering from National Institute of Technology, India and an MBA from University of Louisiana. Ratan has broad experience in strategic sourcing, clinical outsourcing, operations and supply chain improvements in Fortune 500 and growth companies. He started his career in management consulting specializing in supply-chain across different industries and moved to clinical outsourcing in early 2000. In Pharmaceutical industry he worked at Wyeth and Novartis prior to joining Otsuka and he has managed different categories related to clinical outsourcing.
Session Details: Debate Session: What the Clinical Trials Industry Really Want From Their Solution Providers 25-05-2021, 9:45 am View In Agenda

Lynnette Etzel
Associate Director, Relationship Manager,Merck
Biography: Pharmaceutical professional with over 20 years of experience in clinical research, operations, outsourcing and vendor relationship management. Diverse experience in multiple therapeutic areas and various clinical trial phases. Experience leading large cross functional teams and developing supplier governance models. Associate Director at Merck & Co., Inc. in the Portfolio Sourcing and Relationship Management group within Global Clinical Trial Operations. Currently manages Strategic Functional Service Providers within eight Clinical Development Business Units (areas have included Statistics, Regulatory, Data Management, Global Clinical Monitoring, Clinical Sciences, Medical Writing and Clinical Trial Operations). Began my career as a Study Coordinator for the Cardiovascular Disease Prevention Center at Thomas Jefferson University Hospital, Philadelphia, PA. Earned a Masters of Public Health from DREXEL UNIVERSITY COLLEGE OF MEDICINE (formerly MCP HAHNEMANN UNIVERSITY), Philadelphia, PA and a duel Bachelor’s degree from Villanova University.
Session Details: View In Agenda

Kristine Koontz
Head of US Clinical Operations,GlaxoSmithKline
Biography: Kristi Koontz is currently the Head of US Clinical Operations for GSK. Prior to this, she has held a variety of roles across clinical development and global medical affairs. Kristi has established numerous oncology corporate and academic and alliance partnerships, life cycle strategies, external engagement initiatives, and advocacy partnerships. She holds a BS in Biology from The Pennsylvania State University, an MBA from LaSalle University, and is finishing her PhD in Business Psychology from The Chicago School.
Session Details: KEYNOTE - Exploring How Best to Manage a Shifting Portfolio 25-05-2021, 8:45 am View In Agenda

Pam Duffy
Director, Digital & Technology, Pfizer,

Kathy Leach
Senior Director of Clinical Operations,Pfizer
Biography: Kathy Leach is Senior Director, Clinical Study Team Lead at Pfizer. She has been in the pharma industry for 25 years, spanning numerous therapeutic areas, phases and roles supporting clinical trial conduct at several large pharmaceutical companies. Her recent roles have focused on cross functional operational oversight of global programs. Kathy is a certified Project Management Professional, received her bachelor degree from Villanova University and Masters in Organization Leadership from Immaculata.
Session Details: View In Agenda

Frank Leu
CEO, Novapeutics,
Biography:
Frank Leu is a Co-Founder and CEO of Novapeutics at Philadelphia, PA - a biopharma spun-out from the University of Pennsylvania, developing a first-in-class small molecule beta-cell restoration curative for type 2 diabetes. Prior, Frank was at a specialty pharma Verto Institute, developing biologic therapeutics for treating the neuroendocrine cancer. Frank graduated with a Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences in 2001, and then post-doc in a Howard Hughes Medical Institute laboratory at the Rockefeller University in molecular enzymology. He has served as an adjunct instructor at the Rutgers Cancer Institute of NJ, and is an adjunct professor at the pharmacology department of the Thomas Jefferson Medical University. Frank also founded BioPharMatrix developing blockchain solutions to lifescience innovations at all phases, and serves as advisor to the Pennovations center working with 1776 / Benjamins Desk. Frank is a thought leader in the blockchain architecture innovations in the life-sciences and drug development, Frank serves on multiple advisory boards and frequently served as chairman, speaker, moderator, and facilitator for many life-sciences and drug development events.
Session Details: View In Agenda

Terrence Tormey
Former CEO,Kibow Biotech, Inc.
Biography: Tormey has more than 44 years of Sales and Marketing, and Executive experience in the global pharmaceutical market. 2017-2020, Mr. Tormey held the position of Chief Executive Officer at Kibow Biotech, where the company developed product a novel treatment for Chronic Kidney Disease. Prior to Kibow, he was a Member of the Board, and Vice-Chairman of Prevention Pharmaceuticals Inc, where he previously held the position of President/CEO beginning July 2010. From 1985 to 1990, Tormey lead Medical/Hospital/Industrial Sales with Wyeth. From 1990 to 2003, Tormey was with Nelson Communications Worldwide. First, as VP at PDN, and then as President of The Medical Phone Company®, and later as President/COO of Nelson Communication’s flagship company, Nelson Professional Sales (later known as Publicis Selling Solutions), Publicis, S.A., Paris. From 1976 to 1985, Mr. Tormey held Sales & Sales Management positions at Ortho Pharmaceuticals, and then as Director of Sales Staff Management with McNeil CPC (Johnson & Johnson).
Session Details: Debate Session: What the Clinical Trials Industry Really Want From Their Solution Providers 25-05-2021, 9:45 am PANEL DISCUSSION Studying the Importance of Getting A Diverse Patient Group Onto Your Study 25-05-2021, 11:45 am View In Agenda

Timothy Koch
Global Head Key Account Management – Trial Management, Transformative Business Operations within GDO,Novartis
Biography:
Tim Koch has spent the last 18 years working in Big Pharma including time at Johnson & Johnson, GlaxoSmithKline, and currently Novartis, along with prior experience in the Financial Services Industry and the Hospital Setting. He is a Lean Six Sigma Black Belt who’s deepest passion is Metrics and Analytics but has a broad range of experience from Finance to IT to Quality Assurance to Resource & Risk Management. He is known as a domain expert in Clinical Trial Optimization via Data and Technology, supporting the operational delivery of thousands of Trials from feasibility/site selection to recruitment planning/tracking to instream monitoring, resource maximization and risk detection to leading health authority inspections. Tim has been an innovative pioneer, infusing an evidence-based analytical culture in countless areas of the business, building multiple Analytics units from the ground up and launching >50 industry-first analytics platforms to >20,000 users in Drug Development. In his current role as Global Head of Key Account Mgmt, he partners closely with the Trial Mgmt Leadership team providing consultation, solutions and know-how anchored around the use of data, analytics, processes and technology during Trial Delivery.
Session Details: View In Agenda

Michael Child
Vice President Clinical Operations,Arbutus Biopharma
Biography: Mike Child currently holds the position of Vice President, Clinical Operations at Arbutus Biopharma located In Warminster PA, near Philadelphia. Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). Prior to that, Mike spent approximately 31 years at Bristol-Myers Squibb (BMS) near Princeton, NJ where he attained the role of Director, Clinical Operations, Infectious Disease contributing to the global approval of novel therapies designed to treat HIV and Hepatitis C. In addition, while at BMS, Mike spent significant time learning the ways of Drug Development while working in Discovery Labs, in the Data Management Department, and finally in roles of increasing responsibility within Early Development/Clinical Pharmacology. Mike’s additional experience includes that related to due diligence and risk mitigation, outsourcing, model document management, and the maintenance of Standards and Processes. Mike graduated with a BS in Animal Production from The Pennsylvania State University (PSU) and completed graduate coursework in Physiology before leaving PSU for Squibb. Mike was born in Lancaster, PA and currently lives in Newtown, PA where he has raised 2 sons.
Session Details: View In Agenda

Gregory Bergonio
Executive Director, US Clinical Operations,Klus Pharma

Jeremy Cress
Director, Operations,Fibrocell Science
Biography: Jeremy Cress, Director of Operations of Fibrocell Science, has 15 years of experience in the biotech/pharmaceutical industry developing and leading solutions-based strategies across all phases of drug development through commercialization, including global manufacturing and distribution. His management experience at Fibrocell is highlighted with the manufacture and commercial scale-up of the first approved cell therapy for aesthetics, LAVIV® azficel-T. Today, Mr. Cress and his team are working in collaboration with Precigen, Inc., a wholly owned subsidiary of Intrexon Corporation, to advance development of Fibrocell’s gene therapy candidates for the treatment of rare diseases affecting the skin and connective tissue. Currently, the team is focused on FCX-007, the Company’s lead candidate for the treatment of recessive dystrophic epidermolysis bullosa (RDEB)—a devastating, congenital, blistering skin disease with high mortality. Prior to joining Fibrocell in 2011, Mr. Cress was Director of Operations for Fisher Clinical Services where he had responsibility for manufacturing, domestic and international logistics, and distribution and supply chain activities for >30 pharmaceutical companies and >100 clinical trials.
Session Details: View In Agenda

Madeline Geday
Sr Director, Head of Patient Engagement,ERT
Biography:
Though new to ERT, Madeline Geday has more than two decades of senior leadership experience and subject matter expertise within the pharmaceutical industry. After beginning her career as a clinical research associate, Madeline spent 17 years at Merck optimizing both global trials and patient and stakeholder engagement to become director of global patient engagement and innovation, implementing patient-centric methodologies while increasing the diversity of patient representation.
By continuing to incorporate the voice of the patient and other key stakeholders, Madeline provides strategic analysis, enhancement, innovation, and direction at ERT in the areas of patient and site experience, diversity of patient recruitment, health literacy, employee engagement, sales and marketing, and more.
Session Details: PANEL DISCUSSION Studying the Importance of Getting A Diverse Patient Group Onto Your Study 25-05-2021, 11:45 am Mitigating the New Patient Burden in Decentralized Trials 26-05-2021, 12:30 pm View In Agenda

Colleen Kostic
Associate Director, Outsourcing Management,Bristol-Myers Squibb
Biography:
Colleen is a pharmaceutical industry leader experienced in building, changing, and growing teams into highly successful organizations
Session Details: View In Agenda

Brandon Maggio
Associate Director,Boehringer Ingelheim
Biography: I have worked in the industry for 15+ years, and joined Boehringer Ingelheim in 2011. During my tenure at BI, I managed multiple pivotal Phase 3 trials within the Metabolic, CNS, Cardiovascular, and Respiratory therapeutic areas. In 2018, I took on the role of Global Clinical Operations Integration Lead for Decentralized Clinical Trials. This position coordinates with all other supporting trial enabling functions, as well as, facilitation of educational and change management activities for BI’s clinical research ecosystem.
Session Details: View In Agenda

Alice Drumheller
Vice President of Clinical Operations,Sensei Bio
Biography: Alice Drumheller has over twenty years’ experience in the clinical operations area with the focus on executing clinical trials. Prior to joining the Sensei Bio, Alice was Senior Director of Clinical Operations at MacroGenics where she executed the company’s clinical strategy. Previous to MacroGenics, Alice was part of the team at Amgen/Micomet where she contributed to the approval of BLINCYTO®. Alice has held positions of increasing responsibility at large pharmaceutical companies, start-up companies and clinical research organizations, including Nabi Biopharmaceuticals, Bristol-Myers Squibb, Kendle (now Syneos), British Biotech and Henri Beaufour Institute (a subsidiary of Ipsen). Alice holds a BS in Public and Community Health from Southern Connecticut State University in New Haven, CT.
Session Details: View In Agenda

Anna Chepushtanova
Global Innovation Specialist,Nestle Waters

Kristina Dabovic
Director of Clinical Operations,MTEM
Biography: Kristina has excellent interpersonal, verbal and written communication skills; A flexible attitude with respect to work assignments and new learning; Ability to manage multiple and varied tasks with enthusiasm and prioritize workload with attention to detail; Ability to identify and address issues proactively in a timely manner and willingness to work in a matrix environment and to value the importance of teamwork. She also possesses team leadership skills and excellent organizational ability.
Session Details: View In Agenda

Sudip Gangopadhyay
Head of Clinical Digital Solutions,Immunomedics
Biography: Sudip is a performance driven executive with 25+ years of global experience in delivering business value through R&D Digital Technology management. His roles have had progressive scope, complexity and authority for planning and execution of strategic business and technical delivery. He is a proven leader with multi-sector international experience in building organizations, establishing business relationships, developing high performance teams, and innovative clinical digital solutions & services to enable science in accelerating delivery of the drug pipeline. Sudip's specialties include: Significant experience in the global Pharmaceutical and Information Technology industry in a variety of strategic senior management roles. He has a proven ability to lead major change initiatives and transform R&D technology and Clinical Digital Solutions organizations. He has also effectively developed relationships with key business partners and managed diverse stakeholder interests.
Session Details: Moving to An Electronic TMF and The Benefits it can Bring 25-05-2021, 11:45 am View In Agenda

Karrie A Hilsinger
Clinical Program Study Director,Immunomedics
Biography: Karrie Hilsinger is Director, Clinical Operations at Immunomedics. She has been in the pharma industry for 20+ years, spanning numerous therapeutic areas, phases and roles supporting clinical trial conduct at several large pharmaceutical companies, CROs and Medical Device organizations. Her recent roles have focused on cross functional operational oversight of global programs. Karrie has been crucial to leading organization through SOP development, Inspection readiness and successful agency inspections.
Session Details: Debate Session: What the Clinical Trials Industry Really Want From Their Solution Providers 25-05-2021, 9:45 am View In Agenda

Adam Barrows
Clinical Trial Lead & Study Director,Bristol Myers Squibb
Biography: Adam Barrows is a Clinical Trial Lead/Study Director for Bristol-Myers Squibb working in Oncology Clinical Development working on Immuno-Oncology agents in the Emerging Tumors team. Adam started his career in clinical research working for ICON Clinical Research in data management and study start-up. Following his time at ICON, he worked in clinical pharmacology at Wyeth then trial operations at Merck. Having spent the majority of his clinical research profession in clinical operations Adam has shifted his focus to strategic trial design and execution as part of the clinical development team at BMS. As a passionate researcher, Adam has worked across multiple therapeutic areas in every phase of clinical research, from start-up to study closeout and brings his operational skills to the scientific execution of clinical trials.
Session Details: View In Agenda

Nimit Jain
Head of Data Science,ACOE at Novartis

Narayan Lebaka
Director of Clinical Data Management,Rgenix
Biography: Narayan has and ten (10)+ years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward.
Session Details: Exploring how data managers should be analysing data in order to achieve high-quality, statistically accurate findings 26-05-2021, 12:00 pm View In Agenda

,

Mirriam Limage-Pierre
Director of Clinical Data Management, Shionogi,
Biography: With over 15 years of extensive clinical-trial experience, Mirriam has extensive working knowledge of data management and GCP and ICH guidelines. As such, I oversee the activities of direct reports and serve as a mentor. I am also responsible for creating the CRF design and ensuring that all protocol required assessments are being collected and the database is built according to specifications. Specialities include; mentoring, leadership and coaching skills, matrix organization, project management skills, GCP/ICH guidelines, CRF Design, DB development, tables and listings, validations, derivations, database testing, SAE reconciliation, discrepancy management
Session Details: View In Agenda

Phi Tat
Central Monitor Manager,Pfizer
Biography: Phi is currently working as currently working as a Central Monitor (Manager) at Pfizer in the Risk-Based Monitoring (RBM) team to monitor and identify risks associated with conducting clinical trials and the quality/integrity of clinical data. Responsible for timely and high quality risk-based monitoring (RBM) analytics to clinical trial monitoring which utilizes data and site level information to determine needs for performing on-site, remote, and centralized activities and focuses resources on risks that have the most potential to impact patients’ safety and data quality.
Session Details: ROUNDTABLE DISCUSSION: Discussing proven methods for training CMs to successfully identify specific KRIs and modernise Clinical Outcomes Assessments 26-05-2021, 1:30 pm View In Agenda

Lisa Squibb
Senior Associate Director Data Management,Boehringer Ingelheim
Biography: Lisa has been in data management in the pharmaceutical industry for almost 30 years. Prior to working for Boehringer-Ingelheim, Lisa has worked at Bristol-Myers Squibb and Purdue Pharma. She has been involved in several projects under multiple therapeutic areas including immunology, neuroscience, sexual medicine, diabetes and cardiovascular health, and pain management. Lisa holds a Ph.D. in Health Psychology, a Master’s of Public Health and a Master’s of Business Administration in the area of International Business. Lisa is also a volunteer certified Emergency Medical Technician in her local town of Monroe, CT and has been involved in emergency services for nearly 15 years.
Session Details: View In Agenda

Kelly Ragins
Vice President, Global Clinical Trial Strategy & Operations,Bristol-Myers Squibb
Biography: Kelly Ragins joined Bristol-Myers Squibb as Vice President of Clinical Trial Strategy and Operations in February of 2018. In this role, she led program and trial management across the portfolio. With the integration, Kelly will focus on the late development activities including non-registrational, investigator sponsored, and medical affairs trials as a member of the Global Development Operations leadership team. With over 25 years R&D experience with concentration on strategic roles, Kelly has developed expertise in the implementation of departments, effective alliance management, and cross-functional collaboration. Prior to joining BMS, Kelly served as Vice President of Internal Medicine Clinical Strategy at Syneos Health. For many years, she was a leader in the Pfizer Global R&D organization within Oncology operations, and as head of Study Management for Vaccines at Pfizer she co-led the Wyeth portfolio integration. Over her career, Kelly held leadership positions at Amgen in the Global Development organization establishing Clinical Operations Management group. She worked for many years within the Clinical Development & Medical Affairs organization at Merck, and conducted pre-clinical research at the Mayo Clinic. Kelly has a pre-med Bachelor's degree in Anthropology and Spanish, and a Master’s degree in Healthcare Leadership.
Session Details: Debate Session: What the Clinical Trials Industry Really Want From Their Solution Providers 25-05-2021, 9:45 am View In Agenda

Justin Albani
Director, Imaging Services,Invicro
Biography: Justin Albani is the Director of Imaging Services at Invicro, an imaging solutions provider specializing in the application of imaging biomarkers in drug development and clinical research. Justin has over ten years of experience in clinical research and medical imaging, where he focused on imaging operations and data collection, review, and standardization. At Invicro, Justin is responsible for the oversight of global training and imaging equipment qualification across center’s participating in Phase I -III clinical trials, as well as imaging data receipt and processing.
Session Details: View In Agenda

Michelle Marlborough
Chief Product Officer, Product Management,AiCure
Biography: As Chief Product Officer at AiCure, Michelle Marlborough is responsible for the product direction, definition and delivery of the company’s award-winning artificial intelligence platform. With over 24 years of experience in life sciences and software development, Michelle has been at the forefront of transforming clinical trials through innovative technology and analytics and previously held the positions of Vice President of Product Management at Veeva and Vice President of Product Strategy at Medidata Solutions. Before making the shift to the technology sector, Michelle worked in data management roles at GlaxoSmithKline and AstraZeneca. There she experienced firsthand the industry’s struggle with outdated processes and systems. Michelle earned her bachelors of science degree in biology and mathematics from Coventry University.
Session Details: Predictive Dosing: Understanding Patient Behavior to Enhance Trial Efficiency 25-05-2021, 2:15 pm Predictive Dosing: Understanding Patient Behavior to Enhance Trial Efficiency 25-05-2021, 2:15 pm View In Agenda

Madhu Kumar Komuravelli
Data Management Site Head - Associate Director CDM,Regeneron Pharmaceuticals
Biography:
Worked in the Pharmaceutical/Biotech/CRO industry since last 23 years with more than 20 years of experience in the Clinical Data Management area on both Sponsor & CRO Side. Successfully led multi-faceted data management project teams to globalize clinical data management processes, systems & organizations and currently working at Regeneron Pharmaceuticals as the Data Management Site Head (Basking Ridge, NJ)/ Associate Director, CDM. Handled and supported several Clinical Studies (Phase 1 to Phase 4) across various therapeutic areas like Immunology, Oncology, CV, CNS, & Rare diseases. Completely familiar with technology and its role in the Clinical Data Management space and performed/supported several technology related initiatives.
Session Details: View In Agenda

Bill Cooney
President and Chief Innovation Officer,MedPoint Digital
Biography:
Bill Cooney founded MedPoint Digital in 1990. As President and CEO, he continues to lead the strategic growth of a world-class digital services company to the medical industry. Prior to launching MedPoint, Bill was on the Executive Committee and helped start-up Discovery International, the medical education arm of Publicis Healthcare.
In the 1980s, Bill worked in sales and marketing positions at Wyeth and Abbott. He was Business Unit Manager for the Depakote brand at Abbott, and helped form the first telemarketing sales department at Abbott.
Throughout his career, Bill has spoken at numerous healthcare industry events and bylined articles in pharmaceutical trade journals on topics ranging from medical education to research training and digital technology. Bill is Chairman of the Board of Directors for Healthcare Consultants International, Inc., a company providing training and consulting services to healthcare providers and facilities. Bill holds an M.B.A. from the Fisher College of Business of The Ohio State University and a B.A. from The University of Virginia.
Session Details: View In Agenda

Dennis Salotti, MS, MBA, CCRA
Chief Operating Officer,The Avoca Group
Biography: Dennis is a life sciences executive bringing over 18 years of experience in Clinical Research, Technology, and Operations. Offering broad achievements in the Pharmaceutical industry in clinical operations, portfolio management, vendor qualification, relationship management and eClinical solutions. He possesses focused leadership skills to drive results in highly competitive markets.
Session Details: View In Agenda

,

Marie McCarthy
Senior Director of Product Innovation,ICON plc
Biography:
Marie has over 20 years’ experience working in the area of medical devices and in-vitro diagnostics. Her focus for that last 11 years has been the use of wearables and sensors to generate digital endpoints in clinical trials
She has been with ICON for five years working as a Subject Matter Expert in the deployment and use of wearables and sensors in clinical trials. As part of the ICON innovation team she provides insight into outcomes addressed by wearable technology and has designed and led a number of pilot projects focusing on the use of mHealth technologies in redesigning the clinical trial.
Marie has presented at a number of Industry and Scientific Conferences, is a member of a number of industry panels including DIA wearables workstream and DIME and is a co-leads one of the MobliseD work packages and has authored over 50 publications on the use and implementation of wearables in clinical trials. Marie has an MSc and an MBA.
Session Details: Digital Health Technologies –Maximising the value in clinical trials 25-05-2021, 2:15 pm View In Agenda

John Reites
CEO, THREAD,
Biography: Executive intrapreneur turned digital health entrepreneur, my career includes nearly 20 years leading global drug development, clinical research, and decentralized clinical trials (DCTs) for life science organizations. As CEO of THREAD, I lead our global organization in achieving our 1/5/30 mission to modernize clinical research by offering biopharma and CRO customers one (1) comprehensive platform that is five (5) times more inclusive and makes research 30% more efficient. After co-founding and growing THREAD, we were acquired in 2019 by JLL Partners and Water Street with strategic investment for continued growth and focus on accelerating drug development for our customers. Named one of the Top 100 Influencers in Digital Health, I also provide expertise and execution experience in digital health, clinical research innovation, and DCTs. Learn more about John at www.linkedin.com/in/johnreites
Session Details: PANEL DEBATE : The Time, Money and Quality Triangle - is it possible to achieve all three with the coupling of eData management and manual data systems? 26-05-2021, 10:00 am Best Practices to Scale Your Global Hybrid Decentralized Studies 26-05-2021, 11:30 am View In Agenda

Elizabeth Brown
Business Development Manager Clinical Trials Logistics, Americas LS&HC,DHL
Biography: Elizabeth has been an expert in the cold chain life sciences healthcare industry for over 10 years. Her experience spans operations, account management, and business development. She established herself as a subject matter expert on active and passive packaging, and collaborated on education and a solutions portfolio for cold chain pharmaceutical logistics. As part of the DHL Life Sciences & Healthcare sector, Elizabeth drives the cross-divisional development of clinical trials logistics offering. She sits at the head of the marketing work stream, and is a primary stakeholder for marketing collateral and content. She is also a primary contributor to the commercial aspect of the company’s COVID-19 vaccine distribution strategy and public sector initiatives.
Session Details: Shifting gears: Accelerating clinical trial logistics in 2021 & beyond 26-05-2021, 11:30 am View In Agenda

Kelly Brown
Teckro Chief Marketing Officer,Teckro
Biography:
Session Details: Closing the Gap in Clinical Trial Communication 25-05-2021, 12:15 pm View In Agenda

Declan O’Dwyer
Tecko Product Manager,Teckro
Biography:
Session Details: Closing the Gap in Clinical Trial Communication 25-05-2021, 12:15 pm View In Agenda

Andrea Parish
Executive Director, Risk Management & Process Quality,Teckro
Biography: Andrea is a senior-level strategic leader with 19 years of experience spanning clinical research, global quality assurance, strategic alliance management and business process optimization. She is responsible for driving strategic-level decisions that enable Teckro to challenge today’s status quo in the conduct of clinical trial research. She is also responsible for ensuring that Teckro products meet all regulatory requirements, including GCP and data privacy. Andrea holds a Bachelor of Science degree from the University of Tennessee.
Session Details: Closing the Gap in Clinical Trial Communication 25-05-2021, 12:15 pm View In Agenda

,

Matthew McCarty
Vice President & General Manager, ERT,
Biography: Matt is responsible for defining and leading the product strategy for ERT’s digital patient product line, with a focus on direct to patient enablement in both post approval research and patient support. Matt has spent the last 12 years leading teams and innovating products in both the clinical research and commercial healthcare settings to reduce patient burden of participation and to support patients in their healthcare journey. Most recently, Matt was Global Head of Patient Engagement for ICON’s Commercialization & Outcomes division and, prior to that, Head of Direct to Patient Research (Virtual Trials) at IQVIA.
Session Details: View In Agenda

Matthew Maxwell
Chief of Clinical Research Strategy,Life Line Screening
Biography:
Session Details: How to ensure speedy recruitment for your virtual/decentralized trial 25-05-2021, 11:15 am View In Agenda

Mark Matson
Senior Solution Specialist,Medidata
Biography: Mark is a research professional with 25 years in drug development, sales leadership, licensing, and program management. Mark’s experience includes an extensive career at Pfizer in R&D, program leadership at the biotech MannKind Corporation, and stints in sales and sales leadership at IQVIA, Covance, and ICON. Mark joined Medidata through the acquisition of MC10 where he was the VP of Sales. Having earned an honors degree in molecular and cellular from the University of Connecticut, an MBA from Rensselaer Polytechnic Institute, and multiple executive leadership certificates from the Harvard Business School, Mark has been involved in most aspects of drug development throughout his career and is a seasoned corporate leader.
Session Details: 5 Key Considerations for Successfully Deploying your Sensor Strategy 25-05-2021, 12:15 pm View In Agenda

Carol Tester
Vice President, eCOA Partnerships,YPrime
Biography: Carol Tester, Vice President, eCOA Partnerships, focuses on development of global customer relationships to identify ways that YPrime can serve its biopharmaceutical clients. A recognized subject matter expert in eCOA technology, she brings 20 years of industry experience with more than 15 years of operational and strategic business experience. Carol began her career as a member of the Royal Navy before moving into the Life Science industry after 5 years of service. Her industry tenure started in Data Management at Novo Nordisk, Pfizer and Novartis before accepting a Consultant role for Actelion in Switzerland. Her eCOA experience stems from positions as Relationship Manager, Director of Client Relations as well as Program Director with various eCOA vendors. Carol has overseen global study programs, supervised project management teams and managed key account relationships.
Session Details: Is BYOD right for your eCOA Clinical Trial? 26-05-2021, 10:30 am View In Agenda

Celeste A. Elash
Vice President, eCOA Science,YPrime
Biography: Celeste A. Elash, MS, is the Vice President of eCOA Science for YPrime. Throughout her 25-year industry career, Celeste has served as a clinical research scientist, with a variety of contributions to the advancement of patient-focused drug development and eCOA adoption. Celeste has conducted research for Purdue University, Western Psychiatric Institute and Clinic. She also contributed to some of the earliest electronic patient-reported outcomes studies at the University of Pittsburgh. Prior to joining YPrime, Celeste served as an independent consultant to biopharmaceutical companies and both in operations and as clinical science advisor for two eCOA providers. She currently represents YPrime on the Critical Path Institute’s ePRO Consortium.
Session Details: Is BYOD right for your eCOA Clinical Trial? 26-05-2021, 10:30 am View In Agenda

Sheila Rocchio
Chief Marketing Officer, eClinical Solutions
Biography:
Session Details: Digital Strategies to Power #NoGoingBack 26-05-2021, 12:30 pm View In Agenda

Eduardo Aponte
Business Development Associate,Novotech
Biography:
Session Details: Accelerating Clinical Trials in China and the Asia-Pacific 25-05-2021, 9:15 am View In Agenda

Radha Krishnan
Global Head Biorepository Operations & Strategy, Avantor,
Biography: Radha is a cross-functional biopharmaceutical executive with expertise in leading business transformation projects driving process excellence, cost synergies and technological innovation in the management of Clinical trials/Biobanking. Her in-depth understanding of Central lab operations coupled with experience in financial planning and strategic pricing enabled the successful implementation of various technologies supporting the central lab process delivery and optimization.
Session Details: The critical role of biorepositories and archiving in successful clinical research 25-05-2021, 11:15 am View In Agenda

Steven R Cummings
Executive Director, San Francisco Coordinating Center,California Pacific Medical Center Research Institute
Biography:
Session Details: Clinical Trials from Home: The Role of Research Nurses 26-05-2021, 10:30 am View In Agenda

Ellen Weiss
Vice President of Business Development,PCM Trials
Biography: Ellen Weiss joined PCM Trials in April 2019 as Vice President, Business Development. Ms. Weiss has worked to deliver patient-centric services to patients since 2014, including previous roles with CMed Clinical Services and Symphony Clinical Research. Additionally, she has driven the advancement of hospice services at Rainbow Hospice and Palliative Care, a non-profit hospice in Chicago, as both a board member and an on-staff patient advocate. She began her career in the financial services sector and has been an active volunteer for the Healthcare Businesswomen’s Association since 2005, where she works to foster communication across the healthcare industry
Session Details: Clinical Trials from Home: The Role of Research Nurses 26-05-2021, 10:30 am View In Agenda

Robyn Griffith
Executive Director, Project Delivery,PRA Health Sciences
Biography: Robyn C. Griffith has been in the Pharmaceutical R&D industry for over 16 years. She began her career as an Emergency Department R.N., became a Certified Nurse Midwife and worked in that field for over 6 years and then joined Quintiles in 2004 as a CRA. It was at Quintiles that she developed into a Senior Project Manager and has continued her career in this exciting field at other CROs. Her most recent experience was as the Regional Head of Biotech at a competing CRO. She recently joined PRA to help the Biotech division continue to grow in alignment with the upcoming merger. Robyn earned her Bachelor’s Degree of Nursing from Austin Peay State University and her Master’s of Science in Nursing from the University of Colorado. She resides in Colorado Springs, Colorado with her husband and family and enjoys figure skating, snowboarding and enjoying the beautiful outdoors!
Session Details: Biotech Compass: Navigating Competing Priorities 25-05-2021, 1:15 pm Biotech Compass: Navigating Competing Priorities 25-05-2021, 1:15 pm View In Agenda

Jaclyn Lizotte
Vice President of Business Development,PCM Trials
Biography:
Session Details: Clinical Trials from Home: The Role of Research Nurses 26-05-2021, 10:30 am View In Agenda

Mike Hutton
Head of Strategic Relationship Management, EU,Almac
Biography: Mike Hutton graduated from University of East Anglia with a PhD in Biochemistry and spent 10 years in Scientific and Medical Research in Birmingham, Cambridge and Norwich. In 1999, Mike joined a leading central laboratory provider in London in a Project Management capacity before moving to Almac Clinical Technologies in 2002 as a Project Manager. Mike has now been with Almac over 17 years, working in various roles of increasing responsibility, from Project Management to Operational Management, and now, in a tactical commercial role. Mike is currently Head of Strategic Relationship Management, EU and oversees several key clients along with developing new and exciting business in EU and beyond with Almac’s leading Interactive Response Technology.
Session Details: Catching up during COVID: Proven Technology for meeting the accelerated timelines 2021 hybrid clinical trials demand 26-05-2021, 9:30 am View In Agenda

Aernout van Haarst
Director, Scientific Affairs,Celerion
Biography:
Aernout has 25 years of drug development experience at biotechnology companies as well as CROs. This experience includes designing drug development strategies through Proof-of-Concept as well as hands-on experience in the design and conduct of early clinical studies in a breadth of therapeutic areas.
As Director, Scientific Affairs, Aernout is a member of Celerion’s respiratory and vaccine research teams and works closely with external experts in the fields of pulmonology and vaccine development to support drug development programs of Celerion’s clients.
Session Details: Optimizing early clinical trials in special populations 25-05-2021, 11:15 am View In Agenda

Michael Obedoza
Project Manager Clinical, Novotech ,Novotech
Biography: Novotech is internationally recognized as the leading regional full-service contract research organization (CRO) in Asia-Pacific. Novotech has been instrumental in the success of over a thousand Phase I - IV clinical trials for biotechnology companies and has a unique capability in offering expert global product development and regulatory affairs consulting to support global programs.
Session Details: Debate Session: What the Clinical Trials Industry Really Want From Their Solution Providers 25-05-2021, 9:45 am View In Agenda

Cindy Warren
,PCM Trials
Biography:
Session Details: Clinical Trials from Home: The Role of Research Nurses 26-05-2021, 10:30 am View In Agenda

Alexis Mathieu
CEO,FeetMe
Biography: Following his studies at Ecole Polytechnique and UC Berkeley, Alexis has identified unmet clinical needs within rehabilitation. Alexis has built a team of engineers, physicians, designers with broad expertise, ranging from physics to signal processing and biomechanics. He has set up a strong tech culture, including a focus on testing.
Session Details: Delivering value with wearables: the example of a problem-solving approach 25-05-2021, 12:15 pm View In Agenda

Heather DiFruscia
VP, Randomization & Trial Supply Management,Axiom Real-Time Metrics
Biography:
Session Details: Benefits and Advantages of a Unified Platform Approach to Global Studies 25-05-2021, 1:15 pm View In Agenda

Brian Dempster
Senior Director, Global Clinical Management,Axiom Real-Time Metrics
Biography: Brian Dempster has over 25 years of clinical development experience, gained across a variety of therapeutic areas and geographical regions. He began his career as a CRA before being accepted to Amgen’s Leadership and Management Program. During a decade at Amgen, Brian held program leadership positions in Oncology, Endocrinology and Bone Health in Europe, Canada and the US. In 2014 Brian joined Vital Therapies (VTL) where he was instrumental in the creation and execution of clinical development strategy, overseeing the entire Phase II and Phase III programs of VTLs combined device and biotherapeutic system for the treatment of liver failure. Utilizing Fusion eClinical Suite in partnership with Axiom: Before joining Axiom, Brian led the clinical development group at Endologix, which oversaw the global team involved in the pre-approval and post-market clinical development of Endologix’s products, serving patients with a need for abdominal aortic aneurysm sealing and repair. Brian has a thorough understanding of the clinical development process and has used this to successfully bring products to market. This includes leading teams through several regulatory inspections in relation to submissions, to FDA, MHRA and PMDA. Brian has a particular interest and passion for trial documentation standards, having forged the path for introduction and transition of several eTMF programs.
Session Details: Benefits and Advantages of a Unified Platform Approach to Global Studies 25-05-2021, 1:15 pm View In Agenda








With over 40 years’ experience, 600 beds and locations in NA, EU and Asia, Celerion conducts First-in-Human, clinical Proof-of-Concept and patient dose response studies, cardiovascular safety and NDA-enabling clinical pharmacology research. Celerion provides full study services including statistics, data management and biostatistics (including PK/PD analysis), and bioanalytical services.











Advanced Clinical is a global clinical research services organization, providing CRO, FSP, Strategic Resourcing and Consulting Services for biopharmaceutical and medical device organizations. Our company is committed to improving all lives touched by clinical research and we address the hopes of patients and healthcare professionals with industry-leading services and technology in life sciences. Visit our website to learn more about how we deliver a Better Clinical Experience.







Clinical Solutions Group is centered around biopharma solutions with a 19-year track record of delivering high-quality consulting and service offerings to top-tier drug development companies.







Oracle Health Sciences
Oracle is a leading strategic software solutions provider to the health sciences industry, helping pharmaceutical, biotechnology, medical device, and healthcare organizations become the most successful in the world by offering the most innovative products and services that deliver the most compelling customer and shareholder value. Oracle's comprehensive industry solutions include clinical trial management and analysis, electronic data capture, adverse event reporting and pharmacovigilance, and healthcare interoperability. Oracle partners with health sciences industry leaders – including 20 of the top 20 life sciences companies and 14 of the top 14 Fortune Global 500 healthcare organizations – to prevent and cure disease, enhance quality of life, and accelerate insights for better health.



















We are the quantitative imaging experts working across the entire drug development spectrum to better diagnose, characterize, treat and cure disease. Invicro is leading innovation to elucidate biological processes for our pharmaceutical and biotechnology partners around the world. www.invicro.com











WorldCare Clinical
SPONSORSHIP ENQUIRIES
OCT East Coast offers solution providers the opportunity to engage with the local clinical trial industry. The event features thought leadership sessions, a wide ranging exhibition, networking opportunities and much more. To enquire about sponsorship opportunities for the conference, please contact our health team at:
Nick McCudden
Head of Sales – OCT East Coast
E: NicholasMcCudden@arena-international.com
SPEAKER OPPORTUNITIES
The program for the 2021 OCT East Coast has been written in collaboration with the local industry, if you would like to get involved you can contact our team at:
Zoe Mainwaring
Program Director
T: +44 0207 832 4323
E: zoe.mainwaring@arena-international.com